424

Compound name
Idelalisib
Alt Name
CAL-101
Zydelig
GS-1101
Compound Image
Idelalisib.png
SMILES
CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
MW
415.40
Brutto
C22H18FN7O
InChI
InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1
InChI Key
IFSDAJWBUCMOAH-HNNXBMFYSA-N
Approval Jurisdiction
2014 FDA 2014 EMA
Approved for clinical use
Chronic Lymphocytic Leukemia
CAS
870281-82-6
PubChem CID
11625818
Action
PI3K δ
Approved Drug List
1
Commercial Vendor
Gilead Sciences